1. Home
  2. PHAR vs ARRY Comparison

PHAR vs ARRY Comparison

Compare PHAR & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • ARRY
  • Stock Information
  • Founded
  • PHAR 1988
  • ARRY 1989
  • Country
  • PHAR Netherlands
  • ARRY United States
  • Employees
  • PHAR N/A
  • ARRY N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • ARRY Semiconductors
  • Sector
  • PHAR Health Care
  • ARRY Technology
  • Exchange
  • PHAR Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • PHAR 587.5M
  • ARRY 649.7M
  • IPO Year
  • PHAR N/A
  • ARRY 2020
  • Fundamental
  • Price
  • PHAR $10.03
  • ARRY $5.95
  • Analyst Decision
  • PHAR Strong Buy
  • ARRY Buy
  • Analyst Count
  • PHAR 3
  • ARRY 21
  • Target Price
  • PHAR $30.00
  • ARRY $9.84
  • AVG Volume (30 Days)
  • PHAR 3.0K
  • ARRY 5.6M
  • Earning Date
  • PHAR 05-08-2025
  • ARRY 05-06-2025
  • Dividend Yield
  • PHAR N/A
  • ARRY N/A
  • EPS Growth
  • PHAR N/A
  • ARRY N/A
  • EPS
  • PHAR N/A
  • ARRY N/A
  • Revenue
  • PHAR $320,708,000.00
  • ARRY $1,064,767,000.00
  • Revenue This Year
  • PHAR $12.39
  • ARRY $21.75
  • Revenue Next Year
  • PHAR $9.84
  • ARRY $11.66
  • P/E Ratio
  • PHAR N/A
  • ARRY N/A
  • Revenue Growth
  • PHAR 24.13
  • ARRY N/A
  • 52 Week Low
  • PHAR $6.65
  • ARRY $3.76
  • 52 Week High
  • PHAR $11.07
  • ARRY $14.85
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 71.76
  • ARRY 65.12
  • Support Level
  • PHAR $8.60
  • ARRY $4.92
  • Resistance Level
  • PHAR $10.28
  • ARRY $5.92
  • Average True Range (ATR)
  • PHAR 0.30
  • ARRY 0.42
  • MACD
  • PHAR 0.17
  • ARRY 0.16
  • Stochastic Oscillator
  • PHAR 88.79
  • ARRY 96.00

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: